Houlihan Lokey Advises DYCONEX
Dyconex AG, a subsidiary of Micro Systems Technologies Management, has been acquired by Somacis, a portfolio company of Chequers Capital
Sellside Advisor
Houlihan Lokey is pleased to announce that DYCONEX, a subsidiary of Micro Systems Technologies (MST), has been acquired by SOMACIS S.p.A (SOMACIS), a portfolio company of Bain Capital and Chequers Capital. The transaction was completed on 31 July 2024.
DYCONEX, founded in 1964 and headquartered in Bassersdorf, Switzerland, is a premier manufacturer of highly miniaturised and customised PCBs and interconnect solutions, primarily serving the medtech sector. The company produces high-reliability, IPC Class III PCBs for healthcare applications, including hearing aids, pacemakers, defibrillators, cochlear implants, and imaging equipment. DYCONEX’s products are renowned for their precision, reliability, and innovation, driven by a dedicated R&D department and state-of-the-art production facilities. The company employs approximately 200 highly skilled professionals and operates from a cutting-edge facility equipped with advanced machinery and cleanroom spaces.
The acquisition complements SOMACIS’ existing operations and supports the company’s vision to expand its technological capabilities and market reach in the high-end medical PCB segment. The integration of DYCONEX, with its specialised expertise and production capabilities, will further strengthen SOMACIS’ position as a global leader in advanced PCB solutions for various industrial applications.
SOMACIS, based in Italy and backed by Bain Capital and Chequers Capital, is a global provider of high-tech PCBs with a strong presence in the aerospace, defence, and medical industries. Chequers Capital, the former majority owner of SOMACIS, retains a minority shareholding in the company after Bain Capital acquired the controlling shares of SOMACIS on 25 July 2024.
Houlihan Lokey served as the exclusive financial advisor to DYCONEX, advising our client on the entire transaction process. These transactions highlight Houlihan Lokey’s extensive expertise and strong track record in the industrial technology and healthcare sectors.
RELATED: Healthcare, Corporate Finance